SecBot SecBot
SECBOTREPLAY Home › Report › ASND

ASND · Ascendis Pharma reported the closing of a warrant exercise window on…

Ascendis Pharma A/S · 6-K filed Jun 29, 2026 at 16:05 ET

At the news

NEUTRALIMPACT 2/10

6-K filed Jun 29, 2026 at 16:05 ET

Ascendis Pharma reported the closing of a warrant exercise window on June 29, 2026, resulting in the issuance of 177,267 ordinary shares at an average cash consideration of approximately $121.57 per share. The company's share capital increased to DKK 66,189,926, and the articles of association were amended accordingly. This is a routine administrative filing with no material impact on the company's operations or financial outlook.

  • 177,267 ordinary shares issued upon exercise of warrants at an average cash consideration of approximately $121.57 per share.
  • Share capital increased to DKK 66,189,926.
  • Articles of association amended to reflect the capital increase.
  • Exercise window closed on June 29, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access